Optimal cytoreduction for advanced epithelial ovarian cancer

Optimal cytoreduction for advanced epithelial ovarian cancer

This article is review of literature on role of surgery in the initial management of advanced stage ovarian cancer, focusing on the definition of optimum surgical cytoreduction, assessment of resectability, estimation of the risk of postoperative complications. Analyze of published scien- tific data...

Full description

Saved in:

Bibliographic Details
Main Authors:	N. G. Kormosh, K. P. Laktionov, N. S. Kerzhkovskaya
Format:	Article
Language:	Russian
Published:	ABV-press 2014-08-01
Series:	Опухоли женской репродуктивной системы
Subjects:	ovarian cancer stage iii-iv surgical cytoreduction
Online Access:	https://ojrs.abvpress.ru/ojrs/article/view/278
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Optimal cytoreductive surgery in patients with disseminated ovarian cancer (the department’s experience)
by: N. G. Kormosh, et al.
Published: (2014-07-01)

Advances in Cytoreductive Surgery and Combination Therapy for Ovarian Cancer
by: Xiaolan Lv, et al.
Published: (2022-07-01)

Splenectomy during cytoreductive surgery in advanced epithelial ovarian cancer can be predicted
by: Thien-Kim Do, et al.
Published: (2025-06-01)

MANAGEMENT IN EARLY OVARIAN CANCER: STANDARDS AND UNSOLVED PROBLEMS
by: N. G. Kormosh, et al.
Published: (2014-09-01)

Incidence and Predictors of Acute Kidney Injury Following Advanced Ovarian Cancer Cytoreduction at a Tertiary UK Centre: An Exploratory Analysis and Insights from Explainable Artificial Intelligence
by: Elizabeth Ratcliffe, et al.
Published: (2025-01-01)

REPEATED OPTIMAL CYTOREDUCTIVE SURGERIES IN COMBINED MODALITY TREATMENT OF OVARIAN CANCER. CASE REPORT
by: S. V. Molchanov, et al.
Published: (2017-07-01)

Cytoreductive HIPEC-Combined Surgery in Treatment of Advanced Ovarian Cancer
by: M. V. Zabelin, et al.
Published: (2022-06-01)

Placement of delayed absorbable mesh to prevent herniation following left diaphragm peritonectomy during ovarian cancer cytoreduction
by: Ryan M. Kahn, et al.
Published: (2025-04-01)

Investigating the effect of optimal cytoreduction in the context of platinum sensitivity in high‐grade serous ovarian cancer
by: Nicholas Cardillo, et al.
Published: (2022-10-01)

Diagnostic accuracy of artificial intelligence algorithms to predict remove all macroscopic disease and survival rate after complete surgical cytoreduction in patients with ovarian cancer: a systematic review and meta-analysis
by: Somayyeh Noei Teymoordash, et al.
Published: (2025-01-01)

Current Status and Controversies in Neoadjuvant Chemotherapy for Advanced Stage Ovarian Cancer: A Review
by: Jiaxi Li, et al.
Published: (2023-11-01)

Intraoperative use of tranexamic acid to reduce blood loss during cytoreductive surgery for advanced ovarian cancer: A randomized controlled clinical trial
by: Xijun Yang, et al.
Published: (2023-07-01)

Systemic and tumor-specific inflammatory markers VCAM-1 and ICAM-1 as indicators of extent of surgery and oncologic outcome in advanced ovarian cancer
by: Okan Gultekin, et al.
Published: (2025-09-01)

THE VALUE OF CYTOREDUCTIVE SURGERY FOR ISOLATED LYMPH NODE RECURRENCE OF OVARIAN CANCER
by: H. I. Mamajonov, et al.
Published: (2020-07-01)

Optimizing the primary treatment of patients with advanced ovarian cancer
by: S. O. Nikogosyan, et al.
Published: (2016-11-01)

Hyperthermic intraperitoneal chemotherapy after upfront cytoreductive surgery for stage III epithelial ovarian cancer: Follow‐up of long‐term survival
by: Ziying Lei, et al.
Published: (2025-05-01)

Neoadjuvant chemotherapy followed by interval debulking surgery versus primary debulking surgery in the advanced epithelial ovarian cancer- a retrospective cohort study
by: Maričić Slobodan, et al.
Published: (2021-01-01)

Personalised treatment of patients with advanced ovarian cancer: comparative analysis of surgical approaches
by: A. Rybin, et al.
Published: (2025-06-01)

Primary cytoreductive surgery followed by chemotherapy compared to neoadjuvant chemotherapy followed by cytoreduction as a treatment for stage III and IV ovarian cancer (literature review)
by: E. V. Sibirskaya, et al.
Published: (2024-05-01)

EXPERIENCE IN APPLYING THE TECHNOLOGY OF CYTOREDUCTIVE SURGERY WITH HYPERTHERMIC INTRAOPERATIVE INTRAPERITONEAL CHEMOTHERAPY IN THE TREATMENT OF PATIENTS WITH PERITONEAL CARCINOMATOSIS
by: A. V. Shelekhov, et al.
Published: (2018-07-01)

Effect of Ropivacaine Epidural Block Combined with General Anesthesia on the Expression of Oxidative Stress and Immune Indexes in Elderly Patients with Ovarian Cancer Cell Cytoreductive Surgery
by: Jianmei Yang, et al.
Published: (2024-11-01)

Do all patients that undergo a ‘complete’ secondary cytoreductive surgery for platinum-sensitive recurrent ovarian cancer, benefit from it?
by: Bhatt Aditi, et al.
Published: (2024-07-01)

Efficacy and safety of oxaliplatin-based hyperthermic intraperitoneal chemotherapy with secondary cytoreduction for platinum resistant recurrent ovarian cancer: A single-center retrospective cohort study
by: Hua-Hsi Wu, et al.
Published: (2025-08-01)

Cytoreductive surgery with multimodal therapies in advanced or metastatic ovarian, colorectal, and gastric cancers: a systematic review and meta-analysis of randomized trials
by: Xiaojun Yuan, et al.
Published: (2025-07-01)

Clinical efficacy analysis of chemotherapy of isolated neck lymphatic metastasis in advanced epithelial ovarian cancer
by: Hong Liu, et al.
Published: (2025-05-01)

Stage, treatment and survival of low‐grade serous ovarian carcinoma in the Netherlands: A nationwide study
by: Koen De Decker, et al.
Published: (2023-03-01)

Cytoreductive surgery and hyperthermal intraperitoneal chemoperfusion in colorectal cancer and cancer of ovaries: our experience and perspectives of a new method
by: A. V. Malynovskyi, et al.
Published: (2020-10-01)

Efficacy and safety of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy for epithelial ovarian cancer: a systematic review and updated meta-analysis
by: Ahmad Azhar Marzuqi, et al.
Published: (2025-04-01)

Some Aspects of Postoperative Management of Patients with Ovarian Cancer after Cytoreductive Surgery Using Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
by: D. D. Morikov, et al.
Published: (2022-05-01)

Proposed Nodal Cancer Index (NCI) in ovarian carcinomatosis
by: M D Ray, et al.
Published: (2025-04-01)

Neoadjuvant chemotherapy for advanced ovarian cancer: literature data and in vitro studies
by: S. A. Kuznetsov, et al.
Published: (2015-09-01)

DISSEMINATED OVARIAN CANCER: SURGICAL TREATMENT (LITERATURE REVIEW)
by: S. V. Molchanov, et al.
Published: (2016-02-01)

Determining the effect of frailty on survival in advanced ovarian cancer: study protocol for a prospective multicentre national cohort study (FOLERO)
by: Daniel Hunde, et al.
Published: (2025-02-01)

USE OF INTEGRATED DIFFUSION-WEIGHTED MAGNETIC-RESONANCE IMAGING IN PRE-OPERATIVE EVALUATION OF RESECTABILITY OF ADVANCED OVARIAN CANCER
by: A. E. Solopova, et al.
Published: (2017-08-01)

Predicting the outcome of cytoreductive surgery in patients with advanced ovarian cancer
by: M. G. Yakovleva, et al.
Published: (2023-06-01)

Management of Advanced Ovarian Cancer: Current Clinical Practice and Future Perspectives
by: Dimitrios Papageorgiou, et al.
Published: (2025-06-01)

Bevacizumab in Platinum-Sensitive Recurrent Epithelial Ovarian Cancer: A Risk-Stratified Analysis
by: İrem Öner, et al.
Published: (2025-06-01)

Analysis of the effectiveness of primary treatment of stage IA–IIA ovarian cancer
by: V. N. Zhurman, et al.
Published: (2024-11-01)

Comparative analysis of the diagnostyc value of CT and MRI in the assessment of peritoneal carcinomatosis in ovarian cancer
by: Yu. A. Soloveva, et al.
Published: (2025-03-01)

Management and results of treatment of patients with refractory ovarian cancerr
by: N. G. Kormosh, et al.
Published: (2014-08-01)